Novel endocrine therapeutic strategy in endometrial carcinoma targeting estrogen-related receptor α by XCT790 and siRNA.

MLA

Sun, PengMing, et al. “Novel Endocrine Therapeutic Strategy in Endometrial Carcinoma Targeting Estrogen-Related Receptor α by XCT790 and SiRNA.” Cancer Management & Research, vol. 10, Aug. 2018, pp. 2521–35. EBSCOhost, https://doi.org/10.2147/CMAR.S168043.

APA

Sun, P., Mao, X., Gao, M., Huang, M., Chen, L., Ruan, G., Huang, W., Braicu, E. I., & Sehouli, J. (2018). Novel endocrine therapeutic strategy in endometrial carcinoma targeting estrogen-related receptor α by XCT790 and siRNA. Cancer Management & Research, 10, 2521–2535. https://doi.org/10.2147/CMAR.S168043

Chicago

Sun, PengMing, XiaoDan Mao, Min Gao, MeiMei Huang, LiLi Chen, GuanYu Ruan, WeiYi Huang, Elena Ioana Braicu, and Jalid Sehouli. 2018. “Novel Endocrine Therapeutic Strategy in Endometrial Carcinoma Targeting Estrogen-Related Receptor α by XCT790 and SiRNA.” Cancer Management & Research 10 (August): 2521–35. doi:10.2147/CMAR.S168043.